|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6787523B1
(en)
*
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
US20050059802A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
|
US20020052311A1
(en)
*
|
1999-09-03 |
2002-05-02 |
Beka Solomon |
Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders
|
|
DE1257584T1
(de)
|
2000-02-24 |
2003-05-28 |
Lilly Co Eli |
Humanisierte antikörper, die amyloid beta peptid demarkieren
|
|
JP2003516929A
(ja)
*
|
2000-06-01 |
2003-05-20 |
ニユーララブ・リミテツド |
アミロイド形成性疾患の予防および治療
|
|
PE20020574A1
(es)
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
|
US7264810B2
(en)
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
EP1385544B1
(en)
|
2001-04-30 |
2008-09-24 |
Eli Lilly And Company |
Humanized antibodies
|
|
EP2165714B1
(en)
|
2001-04-30 |
2013-10-23 |
Eli Lilly And Company |
Humanized antibodies recognizing the beta-amyloid peptide
|
|
US6906169B2
(en)
*
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
|
PT1944040E
(pt)
|
2001-08-17 |
2012-10-31 |
Univ Washington |
Método de avaliação para a doença de alzheimer
|
|
WO2003076455A2
(en)
*
|
2002-03-05 |
2003-09-18 |
Ramot At Tel-Aviv University Ltd. |
Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP2338510A1
(en)
*
|
2002-07-19 |
2011-06-29 |
Novartis Pharma AG |
Vaccine compositions containing amyloid beta1-6 antigen arrays
|
|
AT413945B
(de)
*
|
2003-01-14 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff für die alzheimer-krankheit
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
NZ567324A
(en)
*
|
2003-02-01 |
2009-08-28 |
Wyeth Corp |
Active immunization to generate antibodies to soluble A-beta
|
|
ATE468886T1
(de)
|
2003-02-10 |
2010-06-15 |
Applied Molecular Evolution |
Abeta-bindende moleküle
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7807171B2
(en)
|
2003-07-25 |
2010-10-05 |
Ac Immune Sa |
Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
|
|
US20050225165A1
(en)
*
|
2004-04-13 |
2005-10-13 |
Naik Sanjeev M |
Brake by-wire control system
|
|
CN101039691B
(zh)
*
|
2004-06-25 |
2013-07-31 |
魁北克益得生物医学公司 |
用于治疗神经疾病的组合物和方法
|
|
AT413946B
(de)
*
|
2004-07-13 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff gegen die alzheimer-krankheit
|
|
CA2576405A1
(en)
*
|
2004-08-11 |
2006-02-16 |
Mitsubishi Chemical Corporation |
Antibody and utilization of the same
|
|
EP1792911A4
(en)
*
|
2004-09-15 |
2008-09-17 |
Univ Yokohama City |
ESSENTIAL AMINO ACID SEQUENCE FOR NEUROSPECIFIC GENE EXPRESSION
|
|
WO2006047670A2
(en)
*
|
2004-10-26 |
2006-05-04 |
Wyeth |
Methods for assessing antibodies to neurodegenerative disease-associated antigens
|
|
GB0424563D0
(en)
*
|
2004-11-05 |
2004-12-08 |
Novartis Ag |
Organic compounds
|
|
EP1838348B1
(en)
|
2004-12-15 |
2013-06-26 |
Janssen Alzheimer Immunotherapy |
Humanized amyloid beta antibodies for use in improving cognition
|
|
US7625560B2
(en)
|
2004-12-15 |
2009-12-01 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
|
DK1853285T3
(da)
*
|
2005-02-01 |
2011-06-27 |
Univ Ramot |
Fremgangsmåde til behandling af inflammation forbundet med amyloidaflejringer og hjerneinflammation som involverer aktiverede mikroglia
|
|
US8691224B2
(en)
|
2005-11-30 |
2014-04-08 |
Abbvie Inc. |
Anti-Aβ globulomer 5F7 antibodies
|
|
HRP20140240T4
(hr)
|
2005-11-30 |
2017-02-24 |
Abbvie Inc. |
Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba
|
|
EP1959996A2
(en)
*
|
2005-12-12 |
2008-08-27 |
AC Immune S.A. |
Monoclonal antibody
|
|
US20090304726A1
(en)
*
|
2006-02-15 |
2009-12-10 |
Ramot At Tel Aviv University Ltd. |
Viral display vehicles for treating multiple sclerosis
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
EP2046833B9
(en)
|
2006-07-14 |
2014-02-19 |
AC Immune S.A. |
Humanized antibody against amyloid beta
|
|
AU2007275258A1
(en)
*
|
2006-07-21 |
2008-01-24 |
Ramot At Tel Aviv University Ltd. |
Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates
|
|
CA2667466A1
(en)
*
|
2006-10-27 |
2008-05-02 |
Ablynx N.V. |
Intranasal delivery of polypeptides and proteins
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
WO2008081008A1
(en)
|
2007-01-05 |
2008-07-10 |
University Of Zurich |
Method of providing disease-specific binding molecules and targets
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
DK2121754T3
(en)
|
2007-01-18 |
2015-02-23 |
Lilly Co Eli |
Pegylated amyloid BETA FAB
|
|
US8895004B2
(en)
|
2007-02-27 |
2014-11-25 |
AbbVie Deutschland GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
|
DK2182983T3
(da)
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
|
AU2008311367B2
(en)
|
2007-10-05 |
2014-11-13 |
Ac Immune S.A. |
Use of anti-amyloid beta antibody in ocular diseases
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
EP2207568B1
(en)
*
|
2007-11-16 |
2017-05-31 |
The Rockefeller University |
Antibodies specific for the protofibril form of beta-amyloid protein
|
|
ITNA20080006A1
(it)
*
|
2008-01-28 |
2009-07-29 |
Consiglio Nazionale Ricerche |
Proteine chimeriche capaci di formare particelle virus-like, che contengono sequenze peptidiche del beta-amiloide e la componente e2 della alfachetoacido deidrogenasi di "geobacillus stearothermophilus", utili per l'induzione di una risposta anticorp
|
|
EP2321348A2
(en)
*
|
2008-07-09 |
2011-05-18 |
University of Zürich |
Method of promoting neurogenesis
|
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
|
NZ592928A
(en)
*
|
2008-11-24 |
2012-12-21 |
Univ Ramot |
Method for treating parkinson' s disease using filamentous bacteriophage
|
|
CN102317316B
(zh)
|
2008-12-19 |
2014-08-13 |
帕尼玛制药股份公司 |
人抗α突触核蛋白自身抗体
|
|
US8987419B2
(en)
|
2010-04-15 |
2015-03-24 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
US20130122033A1
(en)
*
|
2010-07-02 |
2013-05-16 |
Rita De Santis |
Fimh vaccine against urinary tract infections (uti)
|
|
EP2598882B1
(en)
|
2010-07-30 |
2017-07-26 |
AC Immune S.A. |
Safe and functional humanized antibodies for use in treating an amyloidosis
|
|
WO2012020124A1
(en)
|
2010-08-12 |
2012-02-16 |
Ac Immune S.A. |
Vaccine engineering
|
|
EP3533803B1
(en)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antibodies
|
|
JP6027011B2
(ja)
|
2010-10-26 |
2016-11-16 |
エーシー イミューン ソシエテ アノニム |
疎水性部分によって修飾されたペプチドを含むリポソームベースの構築物
|
|
SI2723379T1
(sl)
|
2011-06-23 |
2019-03-29 |
Biogen International Neuroscience Gmbh |
Molekule, ki se vežejo ma anti alfa-sinuklein
|
|
US8877446B2
(en)
*
|
2011-08-26 |
2014-11-04 |
Korea Research Institute Of Bioscience And Biotechnology |
Method for detecting protein-protein interactions in cells
|
|
JP2012102131A
(ja)
*
|
2012-01-05 |
2012-05-31 |
Elan Pharma Internatl Ltd |
アミロイド形成性疾患の予防および治療
|
|
CN104918950B
(zh)
*
|
2012-12-27 |
2018-10-12 |
丝芭博株式会社 |
亲水性重组蛋白的部分精制方法
|
|
EP2940032B1
(en)
*
|
2012-12-27 |
2018-04-25 |
Spiber Inc. |
Extraction method for hydrophilic recombinant protein
|
|
US9102752B2
(en)
|
2013-03-15 |
2015-08-11 |
United Biomedical, Inc. |
Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type
|
|
WO2014150870A2
(en)
|
2013-03-15 |
2014-09-25 |
Altria Client Services Inc. |
Bacteriophage and methods of making and using
|
|
US10065997B2
(en)
|
2013-04-25 |
2018-09-04 |
Spiber Inc. |
Polypeptide porous body and method for producing same
|
|
JP5782580B2
(ja)
|
2013-04-25 |
2015-09-24 |
Ｓｐｉｂｅｒ株式会社 |
ポリペプチドヒドロゲル及びその製造方法
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
US9781929B2
(en)
|
2015-01-29 |
2017-10-10 |
Altria Client Services Llc |
Bacteriophage and methods of using
|
|
US10357056B2
(en)
|
2015-01-29 |
2019-07-23 |
Altria Client Services Llc |
Endolysin from bacteriophage against Geobacillus and methods of using
|
|
CN111201030B
(zh)
|
2017-07-25 |
2024-11-01 |
真和制药有限公司 |
通过阻断tim-3和其配体的相互作用治疗癌症
|
|
CN118370815A
(zh)
|
2017-08-22 |
2024-07-23 |
渤健马萨诸塞州股份有限公司 |
含有抗β淀粉样蛋白抗体的药物组合物
|
|
WO2020160156A2
(en)
|
2019-01-30 |
2020-08-06 |
Immutics, Inc. |
Anti-gal3 antibodies and uses thereof
|
|
EP4157338A4
(en)
|
2020-05-26 |
2024-11-13 |
TrueBinding, Inc. |
METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
|